Nanostructures
- Name
- Nanostructures
- Accession Number
- DBCAT002944
- Description
Materials which have structured components with at least one dimension in the range of 1 to 100 nanometers. These include NANOCOMPOSITES; NANOPARTICLES; NANOTUBES; and NANOWIRES.
- Drugs
Drug Drug Description Ferumoxsil Not Annotated Ferumoxides Not Annotated Astodrimer Astodrimer has been used in trials studying the treatment and prevention of Bacterial Vaginosis. It is a lysine-based dendrimer with naphthalene disulfonic acid surface groups. Matrix-M Matrix-M is a saponin-based adjuvant made of nanometer particles, cholesterol, and phospholipid that is developed by Novavax. This compound is administered alongside vaccines to enhance biological functions: creating robust and... EGEN-001 Investigated for use/treatment in gene therapy and ovarian cancer. AGuIX AGuIX is an investigational brand product consisting of a polysiloxane matrix and gadolinium chelates. It is under development as a radiosensitizer to be used during radiation treatment of malignant glioma. NTLA-2001 NTLA-2001 is a clustered regularly interspaced short palindromic repeats CRISPR/ Cas9-based gene therapy consisting of a single guide RNA targeting the human TTR gene and a messenger RNA encoding Cas9. - Drugs & Drug Targets
Drug Target Type Astodrimer Envelope glycoprotein gp160 target